SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001193125-23-122199
Filing Date
2023-04-27
Accepted
2023-04-27 16:15:19
Documents
1
Period of Report
2022-12-31
Effectiveness Date
2023-04-27

Document Format Files

Seq Description Document Type Size
1 ARS d482104dars.pdf ARS 12691993
  Complete submission text file 0001193125-23-122199.txt   17483491
Mailing Address 200 ARSENAL YARDS BLVD., SUITE 230 WATERTOWN MA 02472
Business Address 200 ARSENAL YARDS BLVD., SUITE 230 WATERTOWN MA 02472 857-285-5314
Kymera Therapeutics, Inc. (Filer) CIK: 0001815442 (see all company filings)

IRS No.: 812992166 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-39460 | Film No.: 23857079
SIC: 2836 Biological Products, (No Diagnostic Substances)